Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.670
+0.020 (0.75%)
At close: Oct 15, 2026, 4:00 PM EDT
2.650
-0.020 (-0.75%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Edesa Biotech Employees
Edesa Biotech had 17 employees as of September 30, 2025. The number of employees increased by 1 or 6.25% compared to the previous year. That makes Edesa Biotech the 38,764th largest employer in the world and 5,626th in the United States.
Employees
17
Change (1Y)
1
Growth (1Y)
6.25%
Revenue / Employee
n/a
Profits / Employee
-$829,528
Market Cap
36.08M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 17 | 1 | 6.25% |
| Sep 30, 2024 | 16 | 0 | - |
| Sep 30, 2023 | 16 | 0 | - |
| Sep 30, 2022 | 16 | 0 | - |
| Sep 30, 2021 | 16 | 4 | 33.33% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| Elicio Therapeutics | 33 |
| Veru Inc. | 20 |
| Filana Therapeutics | 20 |
| Instil Bio | 17 |
| Dogwood Therapeutics | 8 |
| Annovis Bio | 7 |
EDSA News
- 16 hours ago - Edesa Biotech announces FDA clearance for vitiligo study - TheFly
- 16 hours ago - Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study - GlobeNewsWire
- 1 month ago - Edesa Biotech 3.87M share Spot Secondary priced at $5.50 - TheFly
- 1 month ago - Edesa Biotech Announces Pricing of $25.0 Million Public Offering - GlobeNewsWire
- 1 month ago - Edesa Biotech announces offering of common stock and warrants, no amount given - TheFly
- 1 month ago - Edesa Biotech Announces Proposed Public Offering - GlobeNewsWire
- 2 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results - GlobeNewsWire
- 3 months ago - Edesa Biotech files to sell 729,241 common shares for holders - TheFly